Sponsored Symposiums

You’re invited to the sponsored Symposiums at Breast Cancer Trials 46th Annual Scientific Meeting (ASM). You can register for the Symposiums when completing your registration for the ASM.

More information about the Symposiums, including topics and featured guest speakers will be made available over the upcoming months.

Roche Sponsored Lunch Symposium

Roche will hold a Lunch Symposium on Wednesday 23 July. More information including the program and featured guest speakers for this session will be made available over the upcoming months.

Lilly Sponsored Dinner Symposium

Lilly will hold a Dinner Symposium on Wednesday 23 July following the Q&A. More information including the program and guest speakers for this session will be made available over the upcoming months.

Novartis Sponsored Breakfast Symposium (Concurrent)

Novartis will hold a Breakfast Symposium on Thursday 24 July, targeted towards Medical Oncologists. More information including the program and featured guest speakers for this session will be made available over the upcoming months.

BCAL Diagnostics Sponsored Breakfast Symposium (Concurrent)

BCAL Diagnostics will hold a Breakfast Symposium on Thursday 24 July, targeted towards Surgeons. More information including the program and featured guest speakers for this session will be made available over the upcoming months.

Daiichi-Sankyo | AstraZeneca Sponsored Lunch Symposium

Daiichi-Sankyo | AstraZeneca will hold a Lunch Symposium on Thursday 24 July. More information including the program and featured guest speakers for this session will be made available over the upcoming months.

Pfizer Sponsored Breakfast Symposium

Pfizer will hold a Breakfast Symposium on Friday 25 July. More information including the program and featured guest speakers for this session will be made available over the upcoming months.

GILEAD Sponsored Lunch Symposium

GILEAD will hold a Lunch Symposium on Friday 25 July. More information including the program and featured guest speakers for this session will be made available over the upcoming months.